Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the schedule hereto:
Schedule
Product: Benadryl Chesty Forte
Active Ingredient(s): Guaiphenesin 20mg/mL
Bromhexine hydrochloride 0.6mg/mL
Dosage Form: Oral solution
NZ Sponsor: Warner-Lambert Consumer Healthcare Pty Limited
Manufacturer(s): PharmAction Manufacturing Pty Limited, Laverton North, Victoria, Australia
Product: Henry Schein Lidocaine HCl 2% and Epinephrine 1:100 000
Active Ingredient(s): Adrenaline 10µg/mL
Lignocaine hydrochloride (monohydrate) 20mg/mL
Dosage Form: Solution for injection
NZ Sponsor: Henry Schein Regional Limited
Manufacturer(s): Novocol Pharmaceuticals of Canada Inc., Cambridge, Ontario, Canada
Product: Henry Schein Lidocaine HCl 2% and Epinephrine 1:50 000
Active Ingredient(s): Adrenaline 20µg/mL
Lignocaine hydrochloride (monohydrate) 20mg/mL
Dosage Form: Solution for injection
NZ Sponsor: Henry Schein Regional Limited
Manufacturer(s): Novocol Pharmaceuticals of Canada Inc., Cambridge, Ontario, Canada
Dated this 29th day of March 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).